Cargando…

Maintenance use of ketamine for treatment-resistant depression: an open-label pilot study

Detalles Bibliográficos
Autores principales:	Barenboim, Ivan, Lafer, Beny
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Associação Brasileira de Psiquiatria 2018
Materias:	Letters to the Editors
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6899427/ https://www.ncbi.nlm.nih.gov/pubmed/29590266 http://dx.doi.org/10.1590/1516-4446-2017-2380

Ejemplares similares

The R-Stereoisomer of Ketamine as an Alternative for Ketamine for Treatment-resistant Major Depression
por: Hashimoto, Kenji
Publicado: (2014)

S-(+)-ketamine-induced dissociative symptoms as a traumatic experience in patients with treatment-resistant depression
por: Correia-Melo, Fernanda S., et al.
Publicado: (2017)

Safety and efficacy of extended release ketamine tablets in patients with treatment-resistant depression and anxiety: open label pilot study
por: Glue, Paul, et al.
Publicado: (2020)

Intravenous Ketamine Infusions in Treatment-Resistant Bipolar Depression: An Open-Label Naturalistic Observational Study
por: Wilkowska, Alina, et al.
Publicado: (2021)

Transient effects of multi‐infusion ketamine augmentation on treatment‐resistant depressive symptoms in patients with treatment‐resistant bipolar depression – An open‐label three‐week pilot study
por: Zhuo, Chuanjun, et al.
Publicado: (2020)

Structured physical exercise for bipolar depression: an open-label, proof-of concept study
por: Lafer, Beny, et al.
Publicado: (2023)

Safety and efficacy of ketamine infusion in late onset depression, and conversion to treatment response
por: Srivastava, Shrikant, et al.
Publicado: (2015)

A unique case of very low‐dose subcutaneous ketamine use: Maintenance option of ketamine for treatment‐resistant depression
por: Can, Adem T., et al.
Publicado: (2022)

Low dose oral ketamine treatment in chronic suicidality: An open-label pilot study
por: Can, Adem T., et al.
Publicado: (2021)

Neural Correlates of the DEEPP (Anti-suicidal Response to Ketamine in Treatment-Resistant Bipolar Depression) Study: Protocol for a Pilot, Open-Label Clinical Trial
por: Knyahnytska, Yuliya, et al.
Publicado: (2023)

In Response: Dexmedetomidine versus propofol in dilatation and curettage: An open-label pilot randomized controlled trial
por: Tomar, GS
Publicado: (2016)

Comparison of efficacy of ketamine versus thiopentone-assisted modified electroconvulsive therapy in major depression
por: Jagtiani, Amit, et al.
Publicado: (2020)

Magnetic Seizure Therapy for Unipolar and Bipolar Depression: A Systematic Review
por: Cretaz, Eric, et al.
Publicado: (2015)

Ketamine use in the COVID-19 era: be cautious!
por: Suri, Aditi, et al.
Publicado: (2020)

Ketamine: A Convulsant?
por: Kurdi, Madhuri S., et al.
Publicado: (2017)

Esketamine/ketamine for treatment-resistant depression
por: Lacerda, Acioly L.T.
Publicado: (2020)

Reduced functional bladder capacity associated with ketamine use
por: Ramos, Sergio de P., et al.
Publicado: (2019)

Ketamine with Propofol for Endoscopic Procedures
por: Bhalotra, Anju Romina
Publicado: (2018)

Anaesthesia for thymectomy: Use of ketamine-dexmedetomidine without muscle relaxant
por: Varma, Shapna, et al.
Publicado: (2013)

D-galactose supplementation in individuals with PMM2-CDG: results of a multicenter, open label, prospective pilot clinical trial
por: Witters, Peter, et al.
Publicado: (2021)

Ketamine-induced QTc interval prolongation
por: Singh, Tejinder S. Swaran, et al.
Publicado: (2017)

Efficacy and Safety of Aripiprazole for Treatment of Irritability in Children with Autistic Disorder: An Open-Label Study
por: Habibi, Nastaran, et al.
Publicado: (2015)

Clinical Efficacy of Ketamine for Treatment-resistant Depression
por: Bratsos, Sosipatros, et al.
Publicado: (2019)

Magnesium in Ketamine Administration in Treatment-Resistant Depression
por: Górska, Natalia, et al.
Publicado: (2021)

Intubation using dexmedetomidine and ketamine in a child with Pierre Robin sequence
por: DSouza, Shirley, et al.
Publicado: (2012)

Psychiatric and clinical correlates of rapid cycling bipolar disorder: a cross-sectional study
por: Gigante, Alexandre D., et al.
Publicado: (2016)

Outcomes following mepolizumab treatment discontinuation: real-world experience from an open-label trial
por: Ortega, Hector, et al.
Publicado: (2019)

Cushing's Syndrome and Treatment-Resistant Depression
por: Shukla, Lekhansh
Publicado: (2017)

Ketamine as Add-On Treatment in Psychotic Treatment-Resistant Depression
por: Gałuszko-Węgielnik, Maria, et al.
Publicado: (2023)

Comment on: “Low-Dose Ketamine for Outpatient Hysteroscopy.”
por: Raghuraman, M.S.
Publicado: (2021)

Successful use of modafinil in treatment-resistant bipolar depression in an elderly woman
por: Agarwal, Sri Mahavir, et al.
Publicado: (2012)

A Randomized Pilot Trial of Contingency-management Intervention for Patients in during Methadone Maintenance Treatment, Cash vs. Vouchers
por: PIRNIA, Bijan, et al.
Publicado: (2018)

Neurofeedback Treatment on Depressive Symptoms and Functional Recovery in Treatment-Resistant Patients with Major Depressive Disorder: an Open-Label Pilot Study
por: Lee, Young-Ji, et al.
Publicado: (2019)

As an analgesic ketamine versus fentanyl for total intravenous anesthesia
por: Ezici, Musa, et al.
Publicado: (2013)

Implementation of a perioperative ketamine shortage mitigation strategy
por: Dibridge, Julie, et al.
Publicado: (2020)

Ketamine as Monotherapy in Difficult Airways Is Not Ready for Prime Time
por: Driver, Brian E., et al.
Publicado: (2019)

Intravenous ketamine and progressive cholangiopathy in COVID-19 patients
Publicado: (2021)

Ketamine, Interleukin-6, and Vasoplegia: Is Prevention the Best Medicine?
por: Ortoleva, Jamel P.
Publicado: (2023)

Nebulized ketamine in minor bronchoscopy procedures: A possibility
por: Bharti, Neha, et al.
Publicado: (2023)

Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open label non-randomized clinical trial revisited
por: Gautret, Philippe, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_f8o3l69jek5a3k366unfmp5c9m